Contrasting Properties of Polymeric Nanocarriers for MRI-Guided Drug Delivery
Nanomaterials · 25.07.2023 · 13 (15) · 2163
DOI: 10.3390/nano13152163 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nanomaterials, online erschienen am 25.07.2023. Verfasst von Natalia Łopuszyńska und 1 weiteren Autor:innen. Beteiligte Einrichtung: Department of Magnetic Resonance Imaging, Institute of Nuclear Physics Polish Academy of Sciences, 31-342 Cracow, Poland. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 179 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Norway Grants (Poland), Norwegian Financial Mechanism.
Abstract (Originalsprache)
Poor pharmacokinetics and low aqueous solubility combined with rapid clearance from the circulation of drugs result in their limited effectiveness and generally high therapeutic doses. The use of nanocarriers for drug delivery can prevent the rapid degradation of the drug, leading to its increased half-life. It can also improve the solubility and stability of drugs, advance their distribution and targeting, ensure a sustained release, and reduce drug resistance by delivering multiple therapeutic agents simultaneously. Furthermore, nanotechnology enables the combination of therapeutics with biomedical imaging agents and other treatment modalities to overcome the challenges of disease diagnosis and therapy. Such an approach is referred to as “theranostics” and aims to offer a more patient-specific approach through the observation of the distribution of contrast agents that are linked to therapeutics. The purpose of this paper is to present the recent scientific reports on polymeric nanocarriers for MRI-guided drug delivery. Polymeric nanocarriers are a very broad and versatile group of materials for drug delivery, providing high loading capacities, improved pharmacokinetics, and biocompatibility. The main focus was on the contrasting properties of proposed polymeric nanocarriers, which can be categorized into three main groups: polymeric nanocarriers (1) with relaxation-type contrast agents, (2) with chemical exchange saturation transfer (CEST) properties, and (3) with direct detection contrast agents based on fluorinated compounds. The importance of this aspect tends to be downplayed, despite its being essential for the successful design of applicable theranostic nanocarriers for image-guided drug delivery. If available, cytotoxicity and therapeutic effects were also summarized.
Schlagwörter
Stichwörter der Autor:innen
Autor:innen und Institutionen
- Department of Magnetic Resonance Imaging, Institute of Nuclear Physics Polish Academy of Sciences, 31-342 Cracow, Poland.
ORCID-Profile: Natalia Łopuszyńska, Władysław P Węglarz
Förderung
- Norway Grants (Poland)
- Norwegian Financial Mechanism
Zitieren
APA
Łopuszyńska, N., & Węglarz, W. P. (2023). Contrasting Properties of Polymeric Nanocarriers for MRI-Guided Drug Delivery. Nanomaterials, 13(15), 2163. https://doi.org/10.3390/nano13152163
Vancouver
Łopuszyńska N, Węglarz WP. Contrasting Properties of Polymeric Nanocarriers for MRI-Guided Drug Delivery. Nanomaterials. 2023;13(15):2163. doi:10.3390/nano13152163
BibTeX
@article{opuszyska2023,
author = {Łopuszyńska, Natalia and Węglarz, Władysław P},
title = {Contrasting Properties of Polymeric Nanocarriers for MRI-Guided Drug Delivery},
journal = {Nanomaterials},
year = {2023},
volume = {13},
number = {15},
pages = {2163},
doi = {10.3390/nano13152163}
}
EUVIMED